These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29560274)

  • 1. Increase in hepatic and decrease in peripheral insulin clearance characterize abnormal temporal patterns of serum insulin in diabetic subjects.
    Ohashi K; Fujii M; Uda S; Kubota H; Komada H; Sakaguchi K; Ogawa W; Kuroda S
    NPJ Syst Biol Appl; 2018; 4():14. PubMed ID: 29560274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.
    Ohashi K; Komada H; Uda S; Kubota H; Iwaki T; Fukuzawa H; Komori Y; Fujii M; Toyoshima Y; Sakaguchi K; Ogawa W; Kuroda S
    PLoS One; 2015; 10(12):e0143880. PubMed ID: 26623647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of glucose homeostasis in humans with denervated livers.
    Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
    J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.
    Bajaj M; Suraamornkul S; Hardies LJ; Pratipanawatr T; DeFronzo RA
    Int J Obes Relat Metab Disord; 2004 Jun; 28(6):783-9. PubMed ID: 15024400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.
    Cusi K; DeFronzo R
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3077-84. PubMed ID: 10999789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats.
    Park S; Hong SM; Ahn IS
    Neuroendocrinology; 2009; 89(4):387-99. PubMed ID: 19176946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose counterregulation in advanced type 2 diabetes: effect of β-adrenergic blockade.
    Bokhari S; Plummer E; Emmerson P; Gupta A; Meyer C
    Diabetes Care; 2014 Nov; 37(11):3040-6. PubMed ID: 25092686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of glycogen synthase COOH- and NH2-terminal phosphorylation by insulin in obesity and type 2 diabetes mellitus.
    Højlund K; Birk JB; Klein DK; Levin K; Rose AJ; Hansen BF; Nielsen JN; Beck-Nielsen H; Wojtaszewski JF
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4547-56. PubMed ID: 19837931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ketogenic diet impairs energy and glucose homeostasis by the attenuation of hypothalamic leptin signaling and hepatic insulin signaling in a rat model of non-obese type 2 diabetes.
    Park S; Kim DS; Kang S; Daily JW
    Exp Biol Med (Maywood); 2011 Feb; 236(2):194-204. PubMed ID: 21321316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Different establishing conditions of hyperinsulinemic-euglycemic clamp technique among different groups].
    Yang G; Li CL; Tian H; Cheng SW; Li YJ; Cheng XL; Fang FS
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2410-4. PubMed ID: 23158664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats.
    Wu H; Sui C; Xia F; Zhai H; Zhang H; Xu H; Weng P; Lu Y
    Endocr Res; 2016; 41(1):1-7. PubMed ID: 26361069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals.
    Pendergrass M; Bertoldo A; Bonadonna R; Nucci G; Mandarino L; Cobelli C; Defronzo RA
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E92-100. PubMed ID: 16896161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
    Bitar MS
    Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.